CSL Ltd Annual Report 2020

Megan Clark AC BSc (Hons) PhD Age 62 Independent Non-executive Director Director of CSL Limited since February 2016 Dr Clark has significant executive and non-executive experience across a broad range of sectors including scientific research, health, investment banking and financial services, education and mining. Through her roles, Dr Clark brings a broad strategic perspective and global experience, with a focus on risk and proven health, safety and environment and technology performance. Dr Clark was Chief Executive of the Commonwealth Scientific and Industrial Research Organisation (CSIRO) from2009 until November 2014. Prior to joining CSIRO, she was a Director at NMRothschild and Sons (Australia) and held senior positions at BHP, including Vice President, Technology and Vice President, Health, Safety and Environment. Other directorships and offices (current and recent): – Director of Rio Tinto Limited and Rio Tinto Plc (since November 2014); – Head of the Australian Space Agency (since June 2018); – Member of the Australian Advisory Board and Global Advisory Board of the Bank of America Merrill Lynch (since July 2010); – Member of Council of Monash University Council (since April 2015); and – Former Director of Care Australia Limited (fromMay 2015 to June 2020). Board Committee memberships: – Chairman of the Human Resources and Remuneration Committee. – Member of the Corporate Governance and Nomination Committee. – Member of the Innovation and Development Committee. Carolyn Hewson BEc (Hons), MA Age 65 Independent Non-executive Director Director of CSL Limited since December 2019 Ms Hewson is a former investment banker with over 35 years’ experience in the finance sector. She was previously an Executive Director of Schroders Australia Limited and has extensive financial markets, risk management and investment management expertise. She has long-term non-executive experience in a number of sectors bringing a breadth of experience and insight on strategy, capital management, and portfolio optimisation through cycles, financial and non-financial risk, social value, organisational culture and the changing external environment. In 2009, Ms Hewson was made an Officer in the Order of Australia for her services to the broader community and to business. Other directorships and offices (current and recent): – Director of Infrastructure SA (since January 2019); – Member of Federal Government Growth Centres Advisory Committee (since January 2015); – Former Director of BHP Group Limited and BHP Group Plc (fromMarch 2010 to November 2019); – Former Director of Stockland Group (fromMarch 2009 to September 2018); and – Former Trustee Westpac Foundation (fromMay 2015 to May 2019). Board Committee membership: – Member of the Audit and Risk Management Committee. – Member of the Human Resources and Remuneration Committee. – Member of the Corporate Governance and Nomination Committee. Abbas Hussain BSc (Hons) Age 55 Independent Non-executive Director Director of CSL Limited since February 2018 Mr Hussain has executive experience in the biopharmaceutical industry and deep biotechnology industry insight. Through his executive and non-executive roles, Mr Hussain has a broad global perspective and understanding of pharmaceutical manufacturing, product development, risk, health and safety, environment and corporate responsibility. Mr Hussain was the Global President, Pharmaceutical at GlaxoSmithKline (GSK) serving from 2008 to late 2017, where he managed a global pharmaceutical and vaccine business across 150 markets including the US, Europe, Japan and emerging markets. Before GSK he held senior roles with global responsibilities at Eli Lilly. Other directorships and offices (current and recent): – Director of Cochlear Limited (since December 2018); – Director of TargTex SA (since July 2020); – Director of Teva Pharmaceuticals Inc. (since September 2020); – Senior advisor at C-Bridge Capital (since October 2017); – Senior advisor at CellResearch Corporation (since August 2017); – Senior advisor to Indegene Inc. (since July 2020); and – Former Director of ViiV Healthcare Limited (fromOctober 2009 to July 2017); and – Former Director of Immunocore Limited (fromMay 2017 to June 2020). Board Committee memberships: – Member of the Innovation and Development Committee. – Member of the Human Resources and Remuneration Committee. CSL Limited Annual Report 2020 56 Governance 12